chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a medical assistant regarding a multiple unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions, drug allergies or concomitant medications were not reported. On unknown dates in April 2017 (reported as "vaccinations were from 17-APR-2017 through today 24-APR-2017"), patients were vaccinated with improperly stored doses of ROTATEQ oral liquid (strength and dose were not reported) lot number: M040270, expiration date: 29-APR-2018, orally for prophylaxis, as part of immunization series. According to the reporter, ROTATEQ doses were exposed to the following temperature excursions: 5 minutes at 0.9 Celsius degrees (C) (0C to 1C) and 46.9 Fahrenheit (F) (47F to 77F). Previous temperature excursions were 5 minutes at 35.2F, and 5 minutes at 46.9F. No adverse effects were reported. A digital data logger was involved. Additional information has been requested.
No additional adverse effect reported.; M-M-R II, VAQTA and GARDASIL 9 that underwent a temperature excursion (case 01907249) were administered.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent condition, pertinent medical history, concomitant medication, drug reactions or allergies were not reported.  On 09-FEB-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHA) (M-M-R II) (lot #: S018593, expiration date: 17-JUN-2021 or lot #: S023653, expiration date: 30-JUL-2021 (two lot# of vaccines have been reported, no information of which one was administrated to the patient); dose, strength and route were not reported) for prophylaxis.          The vaccines underwent temperature excursions and were stored at 9 degree Celsius (C) to 25 C (8.7 C) for 30 minutes, 2 C to 8 C (8.2 C) for 30 minutes and 9 C to 25 C (9.43 C) for 45 minutes. There was no previous temperature excursion. The digital data logger was involved. No additional adverse effect reported.   This is one of 20 reports received from the same reporter.; Sender's Comments:  US-009507513-2104USA002963: US-009507513-2104USA002970: US-009507513-2104USA002971: US-009507513-2104USA002972: US-009507513-2104USA002973: US-009507513-2104USA002974: US-009507513-2104USA002975: US-009507513-2104USA002976: US-009507513-2104USA002978: US-009507513-2104USA002980: US-009507513-2104USA002981: US-009507513-2104USA002982: US-009507513-2104USA002983: US-009507513-2104USA002984: US-009507513-2104USA002985: US-009507513-2104USA002986: US-009507513-2104USA002987: US-009507513-2104USA002988: US-009507513-2104USA002989:
Numbness on left arm and fingers and pressure under left axillary. V/S 185/90 P-89, R- 18, O2 sat 99%, no SOB. Patient observed for 45 minutes and was taken to ED for further evaluation.
itching; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (itching) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction (Hives and itching). Concomitant products included PREDNISONE from an unknown date to 18-Jan-2021 for Allergic reaction.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching). At the time of the report, PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications included unspecified blood pressure and cholesterol medications.   The patient is taking Allegra for treatment of the events.
The morning after shot, I had vertigo (spinning) when rising.  It will stop when I steady my head, but continues to occur any time I lay down, bend over, or move my head quickly.
rec'd vaccination 8/3/21,  was tested for covid as part of building wide sweep 8/4/21, facility was notified at approx 1500 on 8/5/21 that PCR test was positive code blue was in progress when facility rec'd notification of positive test result- code called at approx 1430 on 8/5/21
5 weeks following the 2nd dose of Pfizer I began having very heavy minstrel cycles with huge clots. This is ongoing and very painful.
Pt recv vax on 10/22/98; on 2/17/99 pt exp flu-like illness of fever, nasal congestion, cough; tx=Sudafed, Tylenol
TEARS; SWEATING; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry date: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case.  No concomitant medications were reported. On an unspecified date, the subject experienced tears, and sweating. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tears and sweating was not reported. This report was non-serious.
Global pain and inflammation so bad I cried. I have a high threshold for pain, having endured migraine with vomiting for decades. Felt like my skin was on fire. Fever 100.6 as compared to my normal 96 or 97. That was the initial 36 hours, which abated, but the aftermath is an exaggeration of my previously existing issues. Brain fog,  being disoriented as to my body in space,  catching half my body in a doorway, for instance. Profound fatigue. Just a hung over feeling in a non-drinker. Straight laced no drugs etc. person.
Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder; shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle; swelling at the injection site; headache; Fatigue; pressure on her shoulder 20 min after the vaccine; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE DISCOMFORT (pressure on her shoulder 20 min after the vaccine), SUBCUTANEOUS EMPHYSEMA (Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder), SWELLING (shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle), INJECTION SITE SWELLING (swelling at the injection site) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event .     On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (pressure on her shoulder 20 min after the vaccine), SWELLING (shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle), INJECTION SITE SWELLING (swelling at the injection site), HEADACHE (headache) and FATIGUE (Fatigue). On an unknown date, the patient experienced SUBCUTANEOUS EMPHYSEMA (Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder). The patient was treated with ANASTROZOLE (ARIMIDEX) ongoing since an unknown date at an unspecified dose and frequency; IBUPROFEN ongoing since an unknown date for dental procedure, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date for For dental procedure, at an unspecified dose and frequency. On 12-Jan-2021, INJECTION SITE SWELLING (swelling at the injection site), HEADACHE (headache) and FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE DISCOMFORT (pressure on her shoulder 20 min after the vaccine) and SWELLING (shoulder raised,swelling on her shoulder, from the base of her neck to her clavicle) had resolved and SUBCUTANEOUS EMPHYSEMA (Subcutaneous Emphysema which impacted on the swelling that was already on her shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided
Swelling, redness, warmth to both thighs the RT much worse than the left. Started on Keflex susp.
ear infections two to three weeks after; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EAR INFECTION (ear infections two to three weeks after) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EAR INFECTION (ear infections two to three weeks after). At the time of the report, EAR INFECTION (ear infections two to three weeks after) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
Information has been received from a female nurse who on 09-NOV-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 650083/0746P).  The patient reported that on 09-NOV-2005 approximately four hours post injection she experienced injection site pain, itching, local swelling, and the site feeling "firm and felt thick".  She reported that on a later unspecified date she developed a rash and open sores at the injection site.  At the time of this report the patient was recovering from the event.  Additional information has been requested.
Swelling of the lips, mouth and tounge.  Lesions on the interior of the top and bottom lip. Ulcers on the top and bottom of the tongue. Chapped lips. Joint pain, body aches, low-grade temp.
felt very weak; Diarrhea; fever of 103.8; Vomiting; Chills; painful arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (felt very weak), PAIN IN EXTREMITY (painful arm), DIARRHOEA (Diarrhea), CHILLS (Chills) and PYREXIA (fever of 103.8) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (penicillin, ibuprofen, and sulfa drugs), Blood pressure high, High cholesterol and Heart disease, unspecified. Concomitant products included AMLODIPINE, LOSARTAN, HYDROCHLOROTHIAZIDE, EZETIMIBE, OMEPRAZOLE, METFORMIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (painful arm). On 03-Feb-2021, the patient experienced CHILLS (Chills) and VOMITING (Vomiting). On 25-Feb-2021, the patient experienced ASTHENIA (felt very weak), DIARRHOEA (Diarrhea) and PYREXIA (fever of 103.8). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form every four hours. At the time of the report, ASTHENIA (felt very weak), PAIN IN EXTREMITY (painful arm), DIARRHOEA (Diarrhea), CHILLS (Chills), PYREXIA (fever of 103.8) and VOMITING (Vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Body temperature: 103.8 (High) 103.8.         Patient was treated with Tylenol and ice cold packs.   This case was linked to MOD-2021-034146 (Patient Link).
Possibly high blood pressure.; she took the shot her arm was hurting; very tired after taking shots; This spontaneous case was reported by a patient and describes the occurrence of HYPERTENSION (Possibly high blood pressure.), VACCINATION SITE PAIN (she took the shot her arm was hurting) and FATIGUE (very tired after taking shots) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (Possibly high blood pressure.), VACCINATION SITE PAIN (she took the shot her arm was hurting) and FATIGUE (very tired after taking shots). At the time of the report, HYPERTENSION (Possibly high blood pressure.), VACCINATION SITE PAIN (she took the shot her arm was hurting) and FATIGUE (very tired after taking shots) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-287530 (Patient Link).
No adverse event. We picked up what was supposed to be COVID-19 Moderna vaccine. Lot numbers and expiration date matched tracking sheet given to us. Color of medication also matched what was stated on Fact Sheet for Healthcare Providers  for the Moderna vaccine. Instead, the medication in the vial was actually COVID -19 antibodies meant for hospital use. After administration for 44 individuals, we received call that the medications had been mixed up. The vials and box that medication came in had no identifying factors to indicate it was not the Moderna vaccine.
12 hours after receiving the vaccine all of my joints ached horribly. It hurt beyond a normal flu pain. I could not do anything but lay perfectly still. Any movement I made was excruciating. This lasted for approximately 18 hours. The following night I had terrible leg cramps in my right leg all over from my ankle to my knee. I have never experienced anything like this before.
covid vaccine breakthrough case  dose 1 Pfizer 1/19/21 EL3249 dose 2 Pfizer 2/9/21 EL9269 dose 3 Pfizer 10/16/22 FF8841
Got rashes on thighs, legs, hands and waist line. Swollen ankles, feet, legs, knees, wrists,  hands and forearms and elbows. Pain associated with swollen parts mentioned.   Had been to ER a couple times. They did blood tests and Ultrasound to legs to find if there were blood clots. Blood tests were normal and no blood clots were found.   Doctors prescribed Steroid medicine (Prednisone). I'm still on steroid medication.
Hot red face and neck; Hot red face and neck; possible slight swelling of face and eyes (minor); possible slight swelling of face and eyes (minor); chills; headache; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL9264 and expiry date: unknown), via an unspecified route of administration on the left arm, on 29Jan2021 15:15 at a single dose for COVID-19 immunization. Medical history included hypertension and kidney disease, and was allergic to bee stings, penicillin, aluminum chloride. Patient was not pregnant at the of vaccination. There were unspecified medications received within 2 weeks of vaccination, and no other vaccine in 4 weeks prior to. The patient experienced hot red face and neck, possible slight swelling of face and eyes (minor), chills and headache on 29Jan2021 15:30. Outcome of the events was recovered. No treatment was received for the events. The reporter considered the events non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.
This spontaneous report as received from a nurse who at the physician's office via a company representative, stated that they would no longer order RECOMBIVAX HB pediatric doses, (Lot# unspecified) dose, frequency and route unspecified, because this vaccine's caps were the same color as SANOFIs flu vaccines, and the physician's office stated they were afraid of mixing the products up. No adverse effects occurred. This is one of several reports received from the same reporter. Additional information has been requested.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF LEFT FEMORAL VEIN HYPOTENSION 10/23/2022 &  11/5/2022  -- RECURRENCE OF SAME SYMPTOMS
3 days after 1st shot:  middle finger joint on right hand swollen (from ring size 9 to 11) over night and very sore and still exhists. 3 or 4 days after 2nd shot:  wrist joint on right hand very sore like arthritis..very painful and still exhists.  Happaned over night. 2nd shot was on 3-11-2021  EP6955 Not sure if these are from vaccination or just coincidence but arthritis does not happen over night.  Sent email to doctor concerning these events.
PATIENT WOKE UP MORNING OF 04/19/21 COVERED IN TINY RED DOTS HEAD TO TOE WITH LARGEST BEING AT INJECTION SITE. THE PATIENT HAS ALSO SUFFERED FROM WORSENING NAUSEA SINCE VACCINE.
Went to bed around 9pm then around 11pm I work up with the worst head ache of my life (which I don't get migraines or headaches often. Last was several years ago and due to dehydration) and then I vomited. I ran a fever by midnight 100.5+. Didn't sleep much due to mainly the headache then by 7am I vomited again. And no I'm no pregnant and haven't been sick at all. I never vomit either.  My head hurt so bad I couldn't open my eyes. Very positional as well. Still hurt badly when lying down but not as much as sitting up and now by mid afternoon the following day I am dizzy. I did get the latex free vaccine. I am able to eat eggs and chicken products. Very much so a terrible pressure head ache and this is my second week at my new job and I had to call in. Very embarrassing.
Cough; Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise); Poor sleep; Chills; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise)), COUGH (Cough), POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and FATIGUE (Fatigue) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M26A and 032M20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included PREDNISOLONE ACETATE, TIMOLOL MALEATE (BETIMOL [TIMOLOL MALEATE]) and OMEPRAZOLE for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and FATIGUE (Fatigue). On 19-Apr-2021, the patient experienced DYSPNOEA (Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise)). On 26-Apr-2021, the patient experienced COUGH (Cough). On 15-Apr-2021, POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and FATIGUE (Fatigue) had resolved. At the time of the report, DYSPNOEA (Trouble drawing a full breath(described as not constant, but there throughout the day; easily more winded after any sort of excercise)) and COUGH (Cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, SARS-CoV-2 test: (Negative) patient got a COVID test, and tested negative.. On 28-Apr-2021, Computerised tomogram: (abnormal) patient went for an outpatient chest CT scan, which revealed that his lungs were mildly hyperinflated.. On an unknown date, Chest X-ray: (normal) chest X-ray (which showed no fluids or masses).. On an unknown date, Oxygen saturation: (abnormal) physician took a pulse oximetry test (which showed that the patient's oxygen saturation went down after any sort of mild exertion).     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment provided was Advil a couple of times.  Description: 28Apr2021, the patient went for an outpatient chest CT scan, which revealed that his lungs were mildly hyperinflated.
1/12/21 Stomach started feeling uncomfortable 1/13/21 Stomach pains and by the evening I started to have a fever, chills, and sweats.  1/14/21 Stomach pains, fever, chiills, sweats, and body aches continued.  1/15/21 Severe stomach pains, fever, chills and body aches. Responded to Health Clinic. Rapid COVID test was negative and per the request of the Doctor I responded to the Emergency Room located at Medical Center. Rapid COVID test negative, Bloodwork completed, CT test conducted, Appendicitis and I had to have an emergency Laparoscopic Appendectomy.
total all body breakout p/2nd dose of vax required pedipred to control p/10 days of breakout w/only antihistamine;
Impaired hearing, tingling over head, dizziness, diaphoretic, unequal and sluggish pupils, R sided weakness and facial drooping, in and out of awareness, R leg drift.
Constant headaches; Chest Pain; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 10:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021 at 03:00, the patient had constant headaches daily and recently chest pain. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient didn't receive treatment for events. The clinical outcome of the events constant headaches and chest pain was not resolved at the time of this report.   No follow-up attempts are possible, information about batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: added information that patient didn't receive treatment for events.
Pt developed fever and urticarial/erythema multiforme like rash. No oral lesions. Resolved 12/10/2009. Follow up  received on 1/4/10 - Vaccine #3 is the diluent for the MMR and varicella vaccine - manufacturer is Merck- See vaccine administration sheet if confusion.